Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Biogen Shares Drop as Tysabri PML Cases Climb to 23, Europe May Seek Drug ‘Holiday’ Luke Timmerman 10/23/09 Boston
Tysabri’s Tally of PML Cases Reaches 13 Luke Timmerman 09/17/09 Boston
Elan Breached Tysabri Partnership With Biogen Idec, Federal Judge Says Luke Timmerman 09/04/09 Boston
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News Rebecca Zacks 08/12/09 Boston
Elan Hits Biogen Idec with Lawsuit to Protect Tysabri Deal with J&J Ryan McBride 08/06/09 Boston
Biogen Gets Int’l Rights to Acorda’s MS Drug Roxanne Palmer 07/01/09 Boston
Biogen Reports 10th PML Case in Tysabri Patient Roxanne Palmer 06/29/09 Boston
Biogen Idec Showdown with Carl Icahn Culminates in Shareholder Vote Today Luke Timmerman 06/03/09 Boston
Icahn’s Plan to Split Up Biogen Idec Would “Destroy Shareholder Value,” Company Says Luke Timmerman 05/15/09 Boston
Avila Therapeutics Hires First CEO Katrine Bosley, Adds $5M from Existing Investors Ryan McBride 05/15/09 Boston
Biogen Idec Pipeline Strong, Tysabri Coming Back; Icahn Would “Weaken” Board, Company Says Luke Timmerman 05/14/09 Boston
Taligen Raises $26M For Inflammation Drugs Luke Timmerman 05/12/09 Boston
Icahn Throws Down the Gauntlet, Attacks Biogen Idec’s “Failed Leadership” Luke Timmerman 05/11/09 Boston
Tysabri May Promote Healing Around Nerves, Study Says Luke Timmerman 04/28/09 Boston
Biogen Idec To Show Off MS Drugs at Seattle Neurology Meeting Luke Timmerman 04/24/09 Boston
Biogen Idec Tysabri Sales Fall Shy of Street Expectations Luke Timmerman 04/16/09 Boston
FDA Allows High-Yield Tysabri Production Ryan McBride 04/16/09 Boston
Rematch Time: Carl Icahn and Biogen Idec Square Off Again Luke Timmerman 04/14/09 Boston
Carl Icahn Aims to Stick “For Sale” Sign on Biogen Idec Lawn Again Luke Timmerman 02/06/09 Boston
Biogen Idec Rival Succeeds in Trial of Oral Pill for Multiple Sclerosis Luke Timmerman 01/23/09 Boston
Seattle’s Top 10 Innovation Stories of the Half-Year (and Others We Just Plain Liked) Gregory T. Huang 12/31/08 Seattle
New RNAi Drugs, Major Cutbacks at Targanta, Big Partnerships for Arqule and Archemix, & More Boston-Area Life Sciences News Wade Roush 12/24/08 Boston
Tysabri Patient Dies of Brain Infection, First Death Since Drug Re-Introduced Luke Timmerman 12/19/08 Boston
Tysabri Patient Diagnosed With PML Luke Timmerman 12/15/08 Boston
Biogen Idec VC Group Sees Opportunity in Tough Market, Has $100M New Allocation to Invest in Biotech Firms Ryan McBride 12/12/08 San Diego
Tysabri’s Roots at the “Hutch,” MediQuest Spurned by FDA, ZymoGenetics Drug Passes Test, & More Seattle-Area Life Sciences News Luke Timmerman 11/06/08 Seattle
A Trio of Tysabri Stories, Genzyme’s Big Deal with Osiris, A Peek Inside a Winning Hedge Fund, & More Life Sciences News Rebecca Zacks 11/05/08 Boston
Tysabri: The Big Multiple Sclerosis Drug That Emerged From “The Hutch” Luke Timmerman 11/04/08 Seattle
Democratic Party Fundraiser Dies, After Friends and Family Pushed To Get Him Tysabri Luke Timmerman 10/31/08 Boston
Biogen Idec, Elan’s Tysabri Linked to First U.S. Case of Brain Infection Luke Timmerman 10/29/08 Boston
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.